Cargando…
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
Diabetic retinopathy is the leading cause of blindness in working age adults, and is projected to be a significant future health concern due to the rising incidence of diabetes. The recent advent of anti-vascular endothelial growth factor (VEGF) antibodies has revolutionized the treatment of diabeti...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037775/ https://www.ncbi.nlm.nih.gov/pubmed/27618014 http://dx.doi.org/10.3390/ijms17091498 |